BioSpace News Archive

Business

Bayer’s 1,500 Layoffs Are Latest Salvo in CEO Bill Anderson’s Company Overhaul

Since taking the helm in 2023, Anderson has embarked on a radical departure from the traditional structure of large pharma companies. Will getting rid of management layers fix Bayer?

May 17, 2024
·
3 min read
·
Greg Slabodkin
FDA

Amgen Wins FDA Approval for Difficult-to-Treat Lung Cancer

Bolstered by promising response data from its Phase II study, Amgen announced Thursday it got the FDA’s green light for its first-in-class bi-specific T-cell engager Imdelltra for extensive-stage small lung cancer.

May 17, 2024
·
2 min read
·
Tristan Manalac
Business

Biogen Drops Ionis-Partnered Assets in ALS, Angelman Syndrome After Early-Stage Readouts

Disappointed with Phase I/II results for two Ionis-partnered programs, one for amyotrophic lateral sclerosis and another for Angelman syndrome, Biogen has opted to not proceed with their development.

May 17, 2024
·
2 min read
·
Tristan Manalac
GSK to Sell Remaining Stake in Haleon, Looks to Raise $1.52B

GSK said Thursday it plans to divest its remaining 4.2% stake in the consumer health spinout, its fourth and final round of selling off Haleon shares worth approximately $1.52 billion.

May 17, 2024
·
2 min read
·
Tristan Manalac
Policy

EU Regulator Pulls Approval for Preterm Labor Drug One Year After FDA

A European Medicines Agency panel on Friday cited a possible but unconfirmed risk of cancer and recommended that hydroxyprogesterone caproate drugs be suspended from the European Union market.

May 17, 2024
·
1 min read
·
Kate Goodwin
Drug Development

Bayer Touts Phase III Results for Menopause Symptom Drug

Bayer on Thursday provided additional data on late-stage studies of its rival drug to Astellas’ Veozah, which met all primary endpoints.

May 17, 2024
·
2 min read
·
Tyler Patchen
Policy

Opinion: How Biopharma Companies Should Prepare for Non-Compete Bans

Life science companies can protect intellectual property in multiple ways, including leveraging IP rights.

May 17, 2024
·
5 min read
·
Justin Crotty
Policy

QuTEM Receives GMP Certificates and Manufacturing Permits for Transmission Electron Microscopy Laboratory from the Swedish Medical Products Agency

QuTEM AB, a leading provider of transmission electron microscopy services, proudly announces the receipt of GMP Certificates and Manufacturing Permits for Independent Quality Control Laboratories issued by the Swedish Medical Products Agency.

May 17, 2024
·
3 min read
The Exercise Period for Spago Nanomedical’s Warrants of Series TO12 Commences Today

Spago Nanomedical AB issued a total of 127,321,212 warrants of series TO12 within the framework of a rights issue of units during the fourth quarter of 2023.

May 17, 2024
·
6 min read
Pharm Country

Psyence Biomed to Participate in the A.G.P. Virtual Healthcare Company Showcase

Psyence Biomedical Ltd (Nasdaq:PBM) (“Psyence Biomed” or the “Company”) today announced that management will host 1x1 meetings with investors during the A.G.P. Virtual Healthcare Company Showcase, which is being held May 21, 2024.

May 17, 2024
·
1 min read